Cargando…
Salvage therapy with Sodium chlorosum (formerly DAC N-055) for cases of refractory lupoid cutaneous leishmaniasis: results from a compassionate use study with 0.09% Sodium chlorosum in amphiphilic basic cream
BACKGROUND: Lupoid cutaneous leishmaniasis (LCL) is known as a rare but serious complication of anthroponotic cutaneous leishmaniasis (ACL) resistant to conventional treatments. Sodium chlorosum, a pro-oxidative preparation of pharmaceutical sodium chlorite (NaClO(2)), has been successfully used for...
Autores principales: | Molkara, Sara, Poursoltani, Elaheh, Stahl, Kurt-Wilhelm, Maleki, Masoud, Khamesipour, Ali, Bogdan, Christian, Salehi, Maryam, Goyonlo, Vahid Mashayekhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883658/ https://www.ncbi.nlm.nih.gov/pubmed/31779597 http://dx.doi.org/10.1186/s12879-019-4518-x |
Ejemplares similares
-
Lupoid cutaneous leishmaniasis in Afghanistan treated with 0.045% DAC N-055
por: Stahl, KW, et al.
Publicado: (2011) -
Interleukin-2 Expression in Lupoid and Usual Types of Old World Cutaneous Leishmaniasis
por: Mashayekhi Goyonlo, Vahid, et al.
Publicado: (2014) -
0.045% DAC N-055 a choice for poor Afghan surgical patients?
por: Stahl, KW, et al.
Publicado: (2011) -
Lupoid cutaneous leishmaniasis: a case report
por: Khaled, Aida, et al.
Publicado: (2011) -
Association Between HTLV-I Infection with Chronic Lupoid Leishmaniasis
por: Pezeshkpoor, Fakhrozaman, et al.
Publicado: (2013)